3 completed. 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Completed 3 |
Follow Seizure Disorder: new trials by email Literature Review of Seizure Disorder trials Research Report on Seizure Disorder
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Trial of Two Fixed Doses of ZX008 (Fenfluramine HCl) in Children and Young Adults With Dravet Syndrome ZX008 (Fenfluramine Hydrochloride), Matching Placebo - Dravet Syndrome, Seizure Disorder | Phase 3 | Completed | Zogenix International Limited, Inc., a subsidiary of Zogenix, Inc. | 262 | 2016-01-15 | 2023-09-28 |
| A Study of the Efficacy and Safety of RWJ-333369 as add-on Therapy in the Treatment of Partial Onset Seizures. RWJ-333369 - Epilepsy, Epilepsy, Focal | Phase 3 | Completed | SK Life Science, Inc. | 563 | 2006-11-01 | 2012-06-18 |
| A Study of the Efficacy and Safety of RWJ-333369 as add-on Therapy in the Treatment of Partial Onset Seizures. RWJ-333369 - Epilepsy, Epilepsy, Focal | Phase 3 | Completed | SK Life Science, Inc. | 566 | 2006-11-01 | 2012-06-20 |
Epilepsy (3) · Seizures (3) · Epilepsies, Partial (2) · Epilepsy, Complex Partial (2) · Brain Diseases (1) · Epilepsies, Myoclonic (1)
Central Nervous System Diseases (3) · Nervous System Diseases (3) · Neurologic Manifestations (3) · Pathological Conditions, Signs and Symptoms (3) · Signs and Symptoms (3) · Brain Diseases (2) · Epilepsy, Generalized (1) · Epileptic Syndromes (1)
S-2-O-carbamoyl-1-o-chlorophenyl-ethanol (2) · Fenfluramine (1)
SK Life Science, Inc. (2) · Zogenix International Limited, Inc., a subsidiary of Zogenix, Inc. (1)
Australia (1) · Belgium (1) · Canada (1) · Denmark (1) · France (1) · Germany (1) · Italy (1) · Japan (1) · Spain (1) · United Kingdom (1) · United States (1)
PMID 19863578, PMID 34870321, PMID 31862249, PMID 33540241, PMID 34676542, PMID 34768178, PMID 37543865